EMA Authorised: Vazkepa (Icosapent ethyl) — Recordati Industria Chimica e Farmaceutica S.p.A.

View source ↗

Summary

EMA authorised Vazkepa (icosapent ethyl) for the treatment of dyslipidemias; the marketing authorization holder is Recordati Industria Chimica e Farmaceutica S.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Hypertriglyceridemia

Drugs mentioned

• Vazkepa (icosapent ethyl)

Snippet

Status: Authorised. Therapeutic area: Dyslipidemias. MAH: Recordati Industria Chimica e Farmaceutica S.p.A.. Decision date: 09/03/2026